A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors. [electronic resource]
Producer: 20040921Description: 1040-8 p. digitalISSN:- 0160-6689
- Adolescent
- Adult
- Ambulatory Care
- Antipsychotic Agents -- adverse effects
- Diagnostic and Statistical Manual of Mental Disorders
- Dibenzothiazepines -- adverse effects
- Dizziness -- chemically induced
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Humans
- Male
- Middle Aged
- Obsessive-Compulsive Disorder -- drug therapy
- Placebos
- Psychiatric Status Rating Scales
- Quetiapine Fumarate
- Selective Serotonin Reuptake Inhibitors -- therapeutic use
- Sleep -- drug effects
- Treatment Outcome
- Xerostomia -- chemically induced
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.